Peel Hunt reiterated their buy rating on shares of Genus (LON:GNS) in a research report released on Monday morning, ThisIsMoney.Co.Uk reports.
A number of other equities research analysts have also recently weighed in on the stock. Stifel Nicolaus initiated coverage on shares of Genus in a research note on Wednesday, May 29th. They set a hold rating and a GBX 2,685 ($35.08) price objective on the stock. Liberum Capital restated a buy rating on shares of Genus in a research note on Friday, September 6th. Finally, Peel Hunt restated a buy rating and set a GBX 3,200 ($41.81) price objective on shares of Genus in a research note on Wednesday, September 11th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Genus presently has an average rating of Buy and a consensus target price of GBX 2,819.17 ($36.84).
Shares of LON GNS opened at GBX 2,916 ($38.10) on Monday. Genus has a fifty-two week low of GBX 2,090 ($27.31) and a fifty-two week high of GBX 2,950 ($38.55). The firm’s 50-day simple moving average is GBX 2,647.60 and its 200 day simple moving average is GBX 2,518.90. The company has a quick ratio of 1.19, a current ratio of 2.01 and a debt-to-equity ratio of 21.92. The stock has a market cap of $1.90 billion and a P/E ratio of 245.04.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Story: What is a support level?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.